Mark S. Klempner

12.2k citations

110 papers · 8.4k indexed · 2 hit papers · h-index 39

Impact in

Parasitology top 0.05%
- Vector-borne infectious diseases
Infectious Diseases top 0.5%
- Viral Infections and Vectors
- Dermatological diseases and infestations

Papers in

Parasitology 41
- Vector-borne infectious diseases 41
Endocrinology 10
- Escherichia coli research studies 7

Co-authors: Barbara Styrt K. Georgilis Charles A. Dinarello Richard Noring Allen C. Steere Linden T. Hu J.W.M. van der Meer Gerhard Lonnemann
Journals: The Journal of Infectious Diseases (18 papers)New England Journal of Medicine (10 papers)Clinical Infectious Diseases (7 papers)Infection and Immunity (6 papers)The Journal of Immunology (5 papers)
Partner nations: United States Austria Slovenia

In The Last Decade

Mark S. Klempner

110 papers receiving 7.8k citations

Hit Papers

align trajectories log scale

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America 2006 · 1.4k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Clinical Infectious Diseases
1989 New England Journal of Medicine

Peers

Countries citing papers authored by Mark S. Klempner

Since Specialization

Citations

This map shows the geographic impact of Mark S. Klempner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Klempner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Klempner more than expected).

Fields of papers citing papers by Mark S. Klempner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Klempner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Klempner. The network helps show where Mark S. Klempner may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark S. Klempner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark S. Klempner Line = papers co-authored together Mark S. Klempner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Formulation Studies to Develop Low-Cost, Orally-Delivered Secretory IgA Monoclonal Antibodies for Passive Immunization Against Enterotoxigenic Escherichia coli Journal of Pharmaceutical Sciences ·Jan Gogarten, Nalinee Sripaung, Ozan S. Kumru, Mark S. Klempner, Yang Wang, Lisa A. Cavacini, Sangeeta B. Joshi, David B. Volkin	2023	1
2	Investigation of a monoclonal antibody against enterotoxigenic Escherichia coli , expressed as secretory IgA1 and IgA2 in plants Gut Microbes ·Audrey Y‐H. Teh, Lisa A. Cavacini, Yue Hu, Ozan S. Kumru, Jian Xiong, David T. Bolick, Sangeeta B. Joshi, Clemens Grünwald‐Gruber, Friedrich Altmann, Mark S. Klempner, Richard L. Guerrant, David B. Volkin, Yang Wang, Julian K‐C.	2021	15
3	Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design Scientific Reports ·Alla Amcheslavsky, Aaron Wallace, Monir Ejemel, Qi Li, Conor McMahon, Matteo Stoppato, Serena Giuntini, Zachary A. Schiller, 薫花谷, Lim Biauw Hok, Ryan M. Schneider, 透玉置, Raimond Heukers, Andrew C. Kruse, Eileen M. Barry, Brian G. Pierce, Mark S. Klempner, Lisa A. Cavacini, Yang Wang	2021	28
4	IgA as a potential candidate for enteric monoclonal antibody therapeutics with improved gastrointestinal stability Vaccine ·Aaron Wallace, Idris Idris, Lim Biauw Hok, Ryan M. Schneider, Mark S. Klempner, Yang Wang, Lisa A. Cavacini	2020	16
5	Preformulation Characterization and Stability Assessments of Secretory IgA Monoclonal Antibodies as Potential Candidates for Passive Immunization by Oral Administration Journal of Pharmaceutical Sciences ·Yue Hu, Ozan S. Kumru, Jian Xiong, Nalinee Sripaung, John M. Hickey, Yang Wang, Lisa A. Cavacini, Mark S. Klempner, Sangeeta B. Joshi, David B. Volkin	2019	16
6	Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection Infection and Immunity ·Serena Giuntini, Matteo Stoppato, Maja Sedic, Monir Ejemel, 薫花谷, 徐彩芬, Zachary A. Schiller, William D. Thomas, Eileen M. Barry, Lisa A. Cavacini, Mark S. Klempner, Yang Wang	2018	19
7	Pre-exposure Prophylaxis With OspA-Specific Human Monoclonal Antibodies Protects Mice Against Tick Transmission of Lyme Disease Spirochetes The Journal of Infectious Diseases ·Yang Wang, Aurélie Kern, Naomi K. Boatright, Zachary A. Schiller, Barbara M. Watson, Monir Ejemel, Colby Souders, Keith A. Reimann, Linden T. Hu, William D. Thomas, Mark S. Klempner	2016	20
8	Controlled Trials of Antibiotic Treatment in Patients with Post-Treatment Chronic Lyme Disease Vector-Borne and Zoonotic Diseases ·Mark S. Klempner	2002	46
9	Differences in Synovial Fluid Levels of Matrix Metalloproteinases Suggest Separate Mechanisms of Pathogenesis in Lyme Arthritis before and after Antibiotic Treatment The Journal of Infectious Diseases ·Bo Lin, Daniel Ainooson - Noonoo, Richard Noring, Allen C. Steere, Mark S. Klempner, Linden T. Hu	2001	38
10	Host—Pathogen Interactions in the Immunopathogenesis of Lyme Disease Journal of Clinical Immunology ·Linden T. Hu, Mark S. Klempner	1997	31
11	Babesiosis in Patients with AIDS: A Chronic Infection Presenting as Fever of Unknown Origin Clinical Infectious Diseases ·Matthew E. Falagas, Mark S. Klempner	1996	65
12	Binding of Human Urokinase Type Plasminogen Activator and Plasminogen to Borrelia Species The Journal of Infectious Diseases ·Mark S. Klempner, Richard Noring, Jonathan Pratama Sinulingga, Dobrowolska Kinga, Rick A. Rogers	1996	42
13	Chronic Granulomatous Disease Presenting in a 69-Year-Old Man New England Journal of Medicine ·Brian Schapiro, Peter E. Newburger, Mark S. Klempner, Mary C. Dinauer	1991	93
14	Infectivity of Borrelia burgdorferi Correlates with Resistance to Elimination by Phagocytic Cells The Journal of Infectious Diseases ·K. Georgilis, Allen C. Steere, Mark S. Klempner	1991	47
15	An Acquired Chemotactic Defect in Neutrophils from Patients Receiving Interleukin-2 Immunotherapy New England Journal of Medicine ·Mark S. Klempner, Richard Noring, James W. Mier, M.B. Atkins	1990	120
16	The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear Cells New England Journal of Medicine ·Stefan Endres, Reza Ghorbani, V E Kelley, K. Georgilis, Gerhard Lonnemann, J.W.M. van der Meer, Joseph G. Cannon, Tina S. Rogers, Mark S. Klempner, Christian Weber, Ernst J. Schaefer, Sheldon Wolff, Charles A. Dinarello Hit paper breakdown →	1989	1561
17	Characterization of the neutrophil respiratory burst in atopy Journal of Allergy and Clinical Immunology ·Barbara Styrt, Ross E. Rocklin, Mark S. Klempner	1988	38
18	Calcium release associated with discharge of specific granule contents from human neutrophils Biochemical and Biophysical Research Communications ·Barbara Styrt, Martin A. Schwartz, Mark S. Klempner	1988	6
19	Lysosomotropic amines modulate neutrophil calcium homeostasis Journal of Cellular Physiology ·Barbara Styrt, Mark S. Klempner	1988	18
20	Comparison of prostaglandins E2 and D2 as inhibitors of respiratory burst in neutrophils from atopic and nonatopic subjects Inflammation ·Barbara Styrt, Mark S. Klempner, Ross E. Rocklin	1988	2

About Mark S. Klempner

Mark S. Klempner is a scholar working on Parasitology, Endocrinology, Infectious Diseases, Immunology and Immunology and Allergy, having authored 110 papers that have together received 8.4k indexed citations. Recurring topics across this work include Vector-borne infectious diseases (41 papers), Viral Infections and Vectors (18 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (14 papers), Immune Response and Inflammation (13 papers), Dermatological diseases and infestations (10 papers), Mosquito-borne diseases and control (9 papers), Toxin Mechanisms and Immunotoxins (8 papers) and Escherichia coli research studies (7 papers). The work is most often cited by research in Parasitology (3.2k citations), Infectious Diseases (2.8k citations), Nutrition and Dietetics (1.3k citations), Immunology (1.5k citations) and Immunology and Allergy (365 citations). Mark S. Klempner has collaborated with scholars based in United States, Austria and Slovenia. Frequent co-authors include Barbara Styrt, K. Georgilis, Charles A. Dinarello, Richard Noring, Allen C. Steere, Linden T. Hu, J.W.M. van der Meer, Gerhard Lonnemann, Joseph G. Cannon and V E Kelley. Their work appears in journals such as The Journal of Infectious Diseases, New England Journal of Medicine, Clinical Infectious Diseases, Infection and Immunity and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact